Nanostructured and Functionalized Calcium Hydroxyapatite Enhances Collagen Production by Human Dermal Fibroblasts Compared With Microstructured Counterparts In Vitro
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026
DOI: 10.1002/jbm.b.70144 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2026. Verfasst von Elizabeth Cristina Iseke Bispo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Hematology and Stem Cells (LHCT), School of Health Sciences, University of Brasilia, Brasília, Brazil. Hauptthemen laut MEDLINE: Durapatite, Fibroblasts, Collagen, Nanostructures. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Apoio à Pesquisa do Distrito Federal.
Abstract (Originalsprache)
Calcium hydroxyapatite (CaHA) is a well‐established biocompatible material widely used to stimulate collagen formation in soft tissues; however, its clinical use is largely restricted to invasive deep dermal injection due to safety concerns associated with microstructured formulations, such as superficial nodule formation and vascular occlusion. Here, we report the development of a nanostructured, lactose‐functionalized CaHA produced by nanospray drying, enabling safer and more versatile delivery strategies. Physicochemical properties were systematically characterized, and biological performance was evaluated in human dermal fibroblasts and co‐culture with peripheral blood mononuclear cells (PBMCs). The resulting nanostructured CaHA (nanoCaHA) exhibited a submicron particle size (181.06 ± 23.83 nm), narrow polydispersity (PDI 0.23 ± 0.17), and a positive surface charge (+11.75 ± 3.63 mV), attributed to surface protonation during processing. NanoCaHA showed no cytotoxic, genotoxic, or irritant effects in vitro and induced a shift in fibroblast cell‐cycle distribution consistent with enhanced proliferative activity. While both nano‐ and microCaHA increased total collagen production, nanoCaHA significantly upregulated COL1A1 and COL3A1 mRNA expression, particularly under PBMC co‐culture conditions, outperforming a commercially available CaHA formulation. Moreover, nanoCaHA sustained collagen production for up to 5 days after treatment withdrawal. Scanning electron microscopy revealed persistent particulate structures closely associated with fibroblasts after washout, while energy‐dispersive X‐ray spectroscopy confirmed that these deposits were enriched in calcium and phosphorus, consistent with CaHA composition. Furthermore, skin permeation assays using porcine skin in Saarbrücken diffusion cells showed that the nanoCaHA formulation significantly increased calcium delivery into the skin (34.53 ± 6.64 μg/cm 2 ) compared to endogenous control levels (23.43 ± 3.96 μg/cm 2 ). Collectively, these findings demonstrate that nanoscale engineering of CaHA modulates cell–material interactions, supporting the development of safer superficial dermal and novel topical/transdermal delivery systems for regenerative aesthetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Hematology and Stem Cells (LHCT), School of Health Sciences, University of Brasilia, Brasília, Brazil.
- Interdisciplinary Biosciences Laboratory, Faculty of Medicine, University of Brasília, Brasília, Brazil.
- AMA-Atomized Modern Actives, Brasília, Brazil.
- Laboratory of Food, Drugs, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia, Brasília, Brazil.
- Green Nanotechnology Group, University of Brasilia, Brasilia, Brazil.
- Laboratory of Bioactive Compounds and Nanobiotechnology (LCBNano), Campus Darcy Ribeiro, University of Brasilia, Brasilia, Brazil.
ORCID-Profile: Marcilio Cunha-Filho, Taís Gratieri
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Apoio à Pesquisa do Distrito Federal
Zitieren
APA
Bispo, E. C. I., de Barcelos, S. M., Contarato, J. L. A., da Silva, A. O., Rocho, R. V., Brathwaite, A. C. N., Amaral, V. A., de Oliveira, P. M., Souto-Silva, M. V., Joanitti, G. A., Cunha-Filho, M., Gelfuso, G. M., de Carvalho, J. L., Saldanha-Araújo, F., & Gratieri, T. (2026). Nanostructured and Functionalized Calcium Hydroxyapatite Enhances Collagen Production by Human Dermal Fibroblasts Compared With Microstructured Counterparts In Vitro. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.70144
Vancouver
Bispo ECI, de Barcelos SM, Contarato JLA, da Silva AO, Rocho RV, Brathwaite ACN, et al. Nanostructured and Functionalized Calcium Hydroxyapatite Enhances Collagen Production by Human Dermal Fibroblasts Compared With Microstructured Counterparts In Vitro. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026. doi:10.1002/jbm.b.70144
BibTeX
@article{Bispo2026,
author = {Bispo, Elizabeth Cristina Iseke and de Barcelos, Stefhani Martins and Contarato, Jonad Logan A and da Silva, Atailson Oliveira and Rocho, Rafael Vieira and Brathwaite, Ana Clara Nogueira and Amaral, Venâncio Alves and de Oliveira, Paula Martins and Souto-Silva, Maria Victória and Joanitti, Graziella Anselmo and Cunha-Filho, Marcilio and Gelfuso, Guilherme Martins and de Carvalho, Juliana Lott and Saldanha-Araújo, Felipe and Gratieri, Taís},
title = {Nanostructured and Functionalized Calcium Hydroxyapatite Enhances Collagen Production by Human Dermal Fibroblasts Compared With Microstructured Counterparts In Vitro},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2026},
doi = {10.1002/jbm.b.70144}
}
EUVIMED